Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease
- PMID: 11823645
- DOI: 10.1126/science.1067389
Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease
Abstract
Parkinson's disease is a movement disorder characterized by degeneration of dopaminergic neurons in the substantia nigra pars compacta. Dopaminergic neuronal loss also occurs in Drosophila melanogaster upon directed expression of alpha-synuclein, a protein implicated in the pathogenesis of Parkinson's disease and a major component of proteinaceous Lewy bodies. We report that directed expression of the molecular chaperone Hsp70 prevented dopaminergic neuronal loss associated with alpha-synuclein in Drosophila and that interference with endogenous chaperone activity accelerated alpha-synuclein toxicity. Furthermore, Lewy bodies in human postmortem tissue immunostained for molecular chaperones, also suggesting that chaperones may play a role in Parkinson's disease progression.
Comment in
-
Neurobiology. Chaperones take flight.Science. 2002 Feb 1;295(5556):809-10. doi: 10.1126/science.1069544. Science. 2002. PMID: 11823628 No abstract available.
Similar articles
-
A Drosophila model of Parkinson's disease.Nature. 2000 Mar 23;404(6776):394-8. doi: 10.1038/35006074. Nature. 2000. PMID: 10746727
-
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.J Neurochem. 2004 Oct;91(2):451-61. doi: 10.1111/j.1471-4159.2004.02728.x. J Neurochem. 2004. PMID: 15447678
-
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8. doi: 10.1073/pnas.152339799. Epub 2002 Jul 16. Proc Natl Acad Sci U S A. 2002. PMID: 12122208 Free PMC article.
-
Experimental models of Parkinson's disease.Nat Rev Neurosci. 2001 May;2(5):325-34. doi: 10.1038/35072550. Nat Rev Neurosci. 2001. PMID: 11331916 Review.
-
Alpha-synuclein and neurodegenerative diseases.Nat Rev Neurosci. 2001 Jul;2(7):492-501. doi: 10.1038/35081564. Nat Rev Neurosci. 2001. PMID: 11433374 Review. No abstract available.
Cited by
-
LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?Front Neurosci. 2020 Jun 17;14:577. doi: 10.3389/fnins.2020.00577. eCollection 2020. Front Neurosci. 2020. PMID: 32625052 Free PMC article. Review.
-
On the design of broad based screening assays to identify potential pharmacological chaperones of protein misfolding diseases.Curr Top Med Chem. 2012;12(22):2504-22. doi: 10.2174/1568026611212220006. Curr Top Med Chem. 2012. PMID: 23339304 Free PMC article. Review.
-
Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases.Exp Neurol. 2012 Nov;238(1):12-21. doi: 10.1016/j.expneurol.2012.06.032. Epub 2012 Jul 5. Exp Neurol. 2012. PMID: 22771760 Free PMC article. Review.
-
Modeling human neurodegenerative diseases in transgenic systems.Hum Genet. 2012 Apr;131(4):535-63. doi: 10.1007/s00439-011-1119-1. Epub 2011 Dec 14. Hum Genet. 2012. PMID: 22167414 Review.
-
Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.Dis Model Mech. 2016 Aug 1;9(8):823-38. doi: 10.1242/dmm.024703. Dis Model Mech. 2016. PMID: 27491084 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
